These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 30466671)

  • 21. [The role of the traditional surgical procedures for gastroesophageal reflux disease cannot be ignored].
    Zhou JH; Tan QY
    Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):672-676. PubMed ID: 32878412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ogawa M; Arihiro S; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Isshi K; Nakada T; Hokari A; Saruta M; Oshio A; Haruma K; Nakada K
    Esophagus; 2021 Apr; 18(2):398-406. PubMed ID: 33136239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging therapeutic options in GERD.
    Woodland P; Amarasinghe G; Sifrim D
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):455-67. PubMed ID: 23998982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the patient with incomplete response to PPI therapy.
    Kahrilas PJ; Boeckxstaens G; Smout AJ
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):401-14. PubMed ID: 23998978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit Ratio.
    Friedman AJ; Elseth AJ; Brockmeyer JR
    Am Surg; 2022 Jan; 88(1):20-27. PubMed ID: 33560890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
    J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Gastroesophageal Reflux Disease.
    Gyawali CP; Fass R
    Gastroenterology; 2018 Jan; 154(2):302-318. PubMed ID: 28827081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory Gastroesophageal Reflux Disease: A Management Update.
    Rettura F; Bronzini F; Campigotto M; Lambiase C; Pancetti A; Berti G; Marchi S; de Bortoli N; Zerbib F; Savarino E; Bellini M
    Front Med (Lausanne); 2021; 8():765061. PubMed ID: 34790683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
    J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory GERD: what is it?
    Fass R; Gasiorowska A
    Curr Gastroenterol Rep; 2008 Jun; 10(3):252-7. PubMed ID: 18625135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Trends in the Management of Gastroesophageal Reflux Disease.
    Sandhu DS; Fass R
    Gut Liver; 2018 Jan; 12(1):7-16. PubMed ID: 28427116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center.
    Bonavina L; Saino G; Bona D; Sironi A; Lazzari V
    J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
    J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.